4,126 results on '"Neurogenic inflammation"'
Search Results
2. Rare presence and function of neuroendocrine cells in the nasal mucosa.
- Author
-
Wils, Tine, Backaert, Wout, Jacobs, Inge, Ruysseveldt, Emma, Cremer, Jonathan, Dilissen, Ellen, Bullens, Dominique M., Talavera, Karel, Steelant, Brecht, Van Gerven, Laura, Martens, Katleen, and Hellings, Peter W.
- Subjects
BRONCHIAL spasm ,EPITHELIAL cell culture ,NASAL mucosa ,NEUROENDOCRINE cells ,GENE expression - Abstract
There is growing evidence that neurogenic inflammation contributes to the pathophysiology of upper airway diseases, with nasal hyperreactivity (NHR) being a key symptom. The rare neuroendocrine cells (NECs) in the epithelium have been linked to the pathophysiology of bronchial and intestinal hyperreactivity, however their presence in the nasal mucosa and their potential role in NHR remains unclear. Therefore, we studied the presence of NECs in the nasal epithelium of controls, allergic rhinitis patients and chronic rhinosinusitis with nasal polyps patients, and their link to NHR. The expression of typical NECs markers, CHGA, ASCL1 and CGRP, were evaluated on gene and protein level in human samples using real-time quantitative PCR (RT-qPCR), western blot, immunohistochemistry fluorescence staining, RNA scope assay, flow cytometry and single cell RNA-sequencing. Furthermore, the change in peak nasal inspiratory flow after cold dry air provocation and visual analogue scale scores were used to evaluate NHR or disease severity, respectively. Limited gene expression of the NECs markers CHGA and ASCL1 was measured in patients with upper airway diseases and controls. Gene expression of these markers did not correlate with NHR severity nor disease severity. In vitro, CHGA and ASCL1 expression was also evaluated in primary nasal epithelial cell cultures from patients with upper airway disease and controls using RT-qPCR and western blot. Both on gene and protein level only limited CHGA and ASCL1 expression was found. Additionally, NECs were studied in nasal biopsies of patients with upper airway diseases and controls using immunohistochemistry fluorescence staining, RNA scope and flow cytometry. Unlike in ileum samples, CHGA could not be detected in nasal biopsies of patients with upper airway diseases and control subjects. Lastly, single cell RNA-sequencing of upper airway tissue could not identify a NEC cluster. In summary, in contrast to the bronchi and gut, there is only limited evidence for the presence of NECs in the nasal mucosa, and without correlation with NHR, thereby questioning the relevance of NECs in upper airway pathology. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Treatment resistance in inclusion body myositis: the role of mast cells.
- Author
-
Acosta, I., Hofer, M., Hilton-Jones, D., Squier, W., and Brady, S.
- Subjects
- *
INCLUSION body myositis , *MYOSITIS , *MAST cells , *CALCITONIN gene-related peptide , *SUBSTANCE P , *CELLULAR inclusions - Abstract
• Several inflammatory pathways have been described in IBM. • Our results show there was a greater number of mast cells present in IBM and neurogenic myositis than in normal muscle and steroid-responsive inflammatory myopathy. • Neurogenic inflammation may play a role in the pathogenesis of IBM and neurogenic myositis, and this could explain in part the lack of response to immunosuppressive treatment of IBM. Inclusion body myositis is the commonest acquired myopathy in those over 50 years of age. Although it is classified as an idiopathic inflammatory myopathy and the most frequent finding on muscle biopsy in inclusion body myositis is an endomysial inflammatory infiltrate, it is clinically distinct from other myositis, including a lack of response to immunosuppressive medication. Neurogenic changes are commonly reported in inclusion body myositis and inflammatory changes are observed in muscle following neurogenic injury. The objective of our study was to explore whether neurogenic inflammation plays a role in the pathogenesis of inclusion body myositis, possibly explaining its resistance to immunosuppression. The number of mast cells and presence of neuropeptides, substance P and calcitonin gene-related peptide, were assessed in 48 cases of inclusion body myositis, 11 cases of steroid responsive myositis, two cases of focal myositis associated with neurogenic injury, and ten normal controls. The number of mast cells in inclusion body myositis focal and myositis associated to neurogenic injury were significantly greater than that observed in steroid responsive myositis. Our findings suggest that neurogenic inflammation mediated through mast cells may play a role in the pathogenesis of inclusion body myositis, and focal myositis associated to neurogenic injury, and thus, explain in some part its lack of response to immunosuppressive treatments. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Intervertebral disc injury triggers neurogenic inflammation of adjacent healthy discs.
- Author
-
Li, Yongchao, Dai, Chen, Wu, Bing, Yang, Liang, Yan, Xiujie, Liu, Tanghua, Chen, Jindong, Zheng, Zhaomin, and Peng, Baogan
- Subjects
- *
INTERVERTEBRAL disk , *NUCLEUS pulposus , *LUMBAR pain , *DORSAL root ganglia , *LABORATORY rats , *SPINAL nerve roots , *SKIN , *ELLAGIC acid - Abstract
Intervertebral disc degeneration is common and may play an important role in low back pain, but it is not well-understood. Previous studies have shown that the outer layer of the annulus fibrosus of a healthy disc is innervated by nociceptive nerve fibers. In the process of disc degeneration, it can grow into the inner annulus fibrosus or nucleus pulposus and release neuropeptides. Disc degeneration is associated with inflammation that produces inflammatory factors and potentiates nociceptor sensitization. Subsequently neurogenic inflammation is induced by neuropeptide release from activated primary afferent terminals. Because the innervation of a lumbar disc comes from multisegmental dorsal root ganglion neurons, does neurogenic inflammation in a degenerative disc initiate neurogenic inflammation in neighboring healthy discs by antidromic activity? This study was based on animal experiments in Sprague-Dawley rats to investigate the role of neurogenic inflammation in adjacent healthy disc degeneration induced by disc injury. This was an experimental study. Seventy-five 12-week-old, male Sprague-Dawley rats were allocated to 3 groups (sham group, disc injury group and disc injury+TrkA antagonist group). The disc injury group was punctured in the tail disc between the eighth and ninth coccygeal vertebrae (Co8–9) to establish an animal model of tail intervertebral disc degeneration. The sham group underwent only skin puncture and the disc injury+TrkA antagonist group was intraperitoneally injected with GW441756 two days before disc puncture. The outcome measure included quantitative real-time polymerase chain reaction and enzyme-linked immunosorbent assay. Disc injury induced an increase in aggrecan, NGF, TrkA, CGRP, SP, IL-1β, and IL-6 mRNA levels in the injured (Co8–9) and adjacent discs (Co7–8), which reached a peak on day 1, then gradually decreased, and returned to normal on day 14. After intraperitoneal injection of GW441756 prior to puncture, the mRNA levels of the above indicators were down-regulated in Co7–8 and Co8–9 intervertebral discs on the 1st and 7th days. The protein content of the above indicators in Co7–8 and Co8–9 intervertebral discs showed roughly the same trend as mRNA levels. Degeneration of one disc can induce neurogenic inflammation of adjacent healthy discs in a rat model. This model supports a key role of neurogenic inflammation in disc degeneration, and may play a role in the experience of low back pain. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. IL-31-dependent neurogenic inflammation restrains cutaneous type 2 immune response in allergic dermatitis.
- Author
-
Braz, Joao, Castellanos, Carlos, Salvatierra, Juan, Sadeghi, Mahsa, Schroeder, Andrew, Caston, Jaela, Munoz-Sandoval, Priscila, Roy, Suparna, Lazarevsky, Steven, Mar, Darryl, Zhou, Connie, Shin, Jeoung-Sook, Ansel, Karl, Basbaum, Allan, Yu, Xiaobing, and Fassett, Marlys
- Subjects
Animals ,Mice ,Cytokines ,Dermatitis ,Atopic ,Immunity ,Neurogenic Inflammation ,Pyroglyphidae ,Skin ,Interleukins - Abstract
Despite robust literature associating IL-31 with pruritic inflammatory skin diseases, its influence on cutaneous inflammation and the interplay between inflammatory and neurosensory pathways remain unmapped. Here, we examined the consequences of disrupting Il31 and its receptor Il31ra in a mouse model of house dust mite (HDM)-induced allergic dermatitis. Il31-deficient mice displayed a deficit in HDM dermatitis-associated scratching, consistent with its well-established role as a pruritogen. In contrast, Il31 deficiency increased the number and proportion of cutaneous type 2 cytokine-producing CD4+ T cells and serum IgE in response to HDM. Furthermore, Il4ra+ monocytes and macrophages capable of fueling a feedforward type 2 inflammatory loop were selectively enriched in Il31ra-deficient HDM dermatitis skin. Thus, IL-31 is not strictly a proinflammatory cytokine but rather an immunoregulatory factor that limits the magnitude of type 2 inflammatory responses in skin. Our data support a model wherein IL-31 activation of IL31RA+ pruritoceptors triggers release of calcitonin gene-related protein (CGRP), which can mediate neurogenic inflammation, inhibit CD4+ T cell proliferation, and reduce T cell production of the type 2 cytokine IL-13. Together, these results illustrate a previously unrecognized neuroimmune pathway that constrains type 2 tissue inflammation in the setting of chronic cutaneous allergen exposure and may explain paradoxical dermatitis flares in atopic patients treated with anti-IL31RA therapy.
- Published
- 2023
6. C. difficile intoxicates neurons and pericytes to drive neurogenic inflammation.
- Author
-
Manion, John, Musser, Melissa, Kuziel, Gavin, Liu, Min, Shepherd, Amy, Wang, Siyu, Lee, Pyung-Gang, Zhao, Leo, Zhang, Jie, Marreddy, Ravi, Goldsmith, Jeffrey, Yuan, Ke, Hurdle, Julian, Gerhard, Ralf, Jin, Rongsheng, Rakoff-Nahoum, Seth, Rao, Meenakshi, and Dong, Min
- Subjects
Animals ,Mice ,Bacterial Toxins ,Calcitonin Gene-Related Peptide ,Clostridioides difficile ,Clostridium Infections ,Neurogenic Inflammation ,Pericytes ,Receptors ,Neurokinin-1 ,Substance P ,Neurons ,Afferent ,Inflammation Mediators ,Cecum ,Signal Transduction - Abstract
Clostridioides difficile infection (CDI) is a major cause of healthcare-associated gastrointestinal infections1,2. The exaggerated colonic inflammation caused by C. difficile toxins such as toxin B (TcdB) damages tissues and promotes C. difficile colonization3-6, but how TcdB causes inflammation is unclear. Here we report that TcdB induces neurogenic inflammation by targeting gut-innervating afferent neurons and pericytes through receptors, including the Frizzled receptors (FZD1, FZD2 and FZD7) in neurons and chondroitin sulfate proteoglycan 4 (CSPG4) in pericytes. TcdB stimulates the secretion of the neuropeptides substance P (SP) and calcitonin gene-related peptide (CGRP) from neurons and pro-inflammatory cytokines from pericytes. Targeted delivery of the TcdB enzymatic domain, through fusion with a detoxified diphtheria toxin, into peptidergic sensory neurons that express exogeneous diphtheria toxin receptor (an approach we term toxogenetics) is sufficient to induce neurogenic inflammation and recapitulates major colonic histopathology associated with CDI. Conversely, mice lacking SP, CGRP or the SP receptor (neurokinin 1 receptor) show reduced pathology in both models of caecal TcdB injection and CDI. Blocking SP or CGRP signalling reduces tissue damage and C. difficile burden in mice infected with a standard C. difficile strain or with hypervirulent strains expressing the TcdB2 variant. Thus, targeting neurogenic inflammation provides a host-oriented therapeutic approach for treating CDI.
- Published
- 2023
7. The microbiota-gut-brainimmune interface in the pathogenesis of neuroinflammatory diseases: a narrative review of the emerging literature.
- Author
-
Warren, Alison, Nyavor, Yvonne, Zarabian, Nikkia, Mahoney, Aidan, and Frame, Leigh A.
- Subjects
ALZHEIMER'S disease ,DISEASE remission ,HUMAN microbiota ,NERVOUS system ,PARKINSON'S disease - Abstract
Importance: Research is beginning to elucidate the sophisticated mechanisms underlying the microbiota-gut-brain-immune interface, moving from primarily animal models to human studies. Findings support the dynamic relationships between the gut microbiota as an ecosystem (microbiome) within an ecosystem (host) and its intersection with the host immune and nervous systems. Adding this to the effects on epigenetic regulation of gene expression further complicates and strengthens the response. At the heart is inflammation, which manifests in a variety of pathologies including neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Multiple Sclerosis (MS). Observations: Generally, the research to date is limited and has focused on bacteria, likely due to the simplicity and cost-effectiveness of 16s rRNA sequencing, despite its lower resolution and inability to determine functional ability/alterations. However, this omits all other microbiota including fungi, viruses, and phages, which are emerging as key members of the human microbiome. Much of the research has been done in pre-clinical models and/ or in small human studies in more developed parts of the world. The relationships observed are promising but cannot be considered reliable or generalizable at this time. Specifically, causal relationships cannot be determined currently. More research has been done in Alzheimer's disease, followed by Parkinson's disease, and then little in MS. The data for MS is encouraging despite this. Conclusions and relevance: While the research is still nascent, the microbiota-gut-brain-immune interface may be a missing link, which has hampered our progress on understanding, let alone preventing, managing, or putting into remission neurodegenerative diseases. Relationships must first be established in humans, as animal models have been shown to poorly translate to complex human physiology and environments, especially when investigating the human gut microbiome and its relationships where animal models are often overly simplistic. Only then can robust research be conducted in humans and using mechanistic model systems. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction.
- Author
-
Sun, Meiyan, Mao, Sui, Wu, Chao, Zhao, Xiaoyong, Guo, Chengxiao, Hu, Jun, Xu, Shijin, Zheng, Fen, Zhu, Guoqing, Tao, Hui, He, Shufang, Hu, Ji, and Zhang, Ye
- Subjects
- *
VENTRICULAR remodeling , *HEART failure , *MYOCARDIAL infarction , *DORSAL root ganglia , *NERVOUS system , *KNOCKOUT mice , *IMMUNE system - Abstract
BACKGROUND: Heart failure is associated with a high rate of mortality and morbidity, and ventricular remodeling invariably precedes heart failure. Ventricular remodeling is fundamentally driven by mechanotransduction that is regulated by both the nervous system and the immune system. However, it remains unknown which key molecular factors govern the neuro/immune/cardio axis that underlies mechanotransduction during ventricular remodeling. Here, we investigated whether the mechanosensitive Piezo cation channel–mediated neurogenic inflammatory cascade underlies ventricular remodeling–related mechanotransduction. METHODS: By ligating the left coronary artery of rats to establish an in vivo model of chronic myocardial infarction (MI), lentivirus-mediated thoracic dorsal root ganglion (TDRG)–specific Piezo1 knockdown rats and adeno-associated virus–PHP.S—mediated TDRG neuron–specific Piezo1 knockout mice were used to investigate whether Piezo1 in the TDRG plays a functional role during ventricular remodeling. Subsequently, neutralizing antibody–mediated TDRG IL-6 (interleukin-6) inhibition rats and adeno-associated virus–PHP.S—mediated TDRG neuron–specific IL-6 knockdown mice were used to determine the mechanism underlying neurogenic inflammation. Primary TDRG neurons were used to evaluate Piezo1 function in vitro. RESULTS: Expression of Piezo1 and IL-6 was increased, and these factors were functionally activated in TDRG neurons at 4 weeks after MI. Both knockdown of TDRG-specific Piezo1 and deletion of TDRG neuron–specific Piezo1 lessened the severity of ventricular remodeling at 4 weeks after MI and decreased the level of IL-6 in the TDRG or heart. Furthermore, inhibition of TDRG IL-6 or knockdown of TDRG neuron–specific IL-6 also ameliorated ventricular remodeling and suppressed the IL-6 cascade in the heart, whereas the Piezo1 level in the TDRG was not affected. In addition, enhanced Piezo1 function, as reflected by abundant calcium influx induced by Yoda1 (a selective agonist of Piezo1), led to increased release of IL-6 from TDRG neurons in mice 4 weeks after MI. CONCLUSIONS: Our findings point to a critical role for Piezo1 in ventricular remodeling at 4 weeks after MI and reveal a neurogenic inflammatory cascade as a previously unknown facet of the neuronal immune signaling axis underlying mechanotransduction. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Meningeal mast cell‐mediated mechanisms of cholinergic system modulation in neurogenic inflammation underlying the pathophysiology of migraine.
- Author
-
Kilinc, Erkan, Torun, Ibrahim Ethem, and Baranoglu Kilinc, Yasemin
- Subjects
- *
CHOLINERGIC mechanisms , *PARASYMPATHOMIMETIC agents , *CALCITONIN gene-related peptide , *MIGRAINE , *CHOLINERGIC receptors , *SUMATRIPTAN , *SPREADING cortical depression - Abstract
Growing evidence indicates that the parasympathetic system is implicated in migraine headache. However, the cholinergic mechanisms in the pathophysiology of migraine remain unclear. We investigated the effects and mechanisms of cholinergic modulation and a mast cell stabilizer cromolyn in the nitroglycerin‐induced in vivo migraine model and in vitro hemiskull preparations in rats. Effects of cholinergic agents (acetylcholinesterase inhibitor neostigmine, or acetylcholine, and muscarinic antagonist atropine) and mast cell stabilizer cromolyn or their combinations were tested in the in vivo and in vitro experiments. The mechanical hyperalgesia was assessed by von Frey hairs. Calcitonin gene‐related peptide (CGRP) and C‐fos levels were measured by enzyme‐linked immunosorbent assay. Degranulation and count of meningeal mast cells were determined by toluidine‐blue staining. Neostigmine augmented the nitroglycerin‐induced mechanical hyperalgesia, trigeminal ganglion CGRP levels, brainstem CGRP, and C‐fos levels, as well as degranulation of mast cells in vivo. Atropine inhibited neostigmine‐induced additional increases in CGRP levels in trigeminal ganglion and brainstem while it failed to do this in the mechanical hyperalgesia, C‐fos levels, and the mast cell degranulation. However, all systemic effects of neostigmine were abolished by cromolyn. The cholinergic agents or cromolyn did not alter basal release of CGRP, in vitro, but cromolyn alleviated the CGRP‐inducing effect of capsaicin while atropine failed to do it. These results ensure for a first time direct evidence that endogenous acetylcholine contributes to migraine pathology mainly by activating meningeal mast cells while muscarinic receptors are involved in CGRP release from trigeminal ganglion and brainstem, without excluding the possible role of nicotinic cholinergic receptors. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Substance P/calcitonin gene‐related peptide and their receptors expression in human periodontal ligament after root canal preparation with five different systems.
- Author
-
Caviedes‐Bucheli, Javier, Muñoz‐Alvear, Hernan Dario, Lopez‐Moncayo, Luis Fernando, Kacharaju, Kranthi Raja, Velasquez‐Rivera, Adriana Carolina, Carlosama‐Recalde, Luis Alberto, Pazmiño, Juan Camilo, Gomez‐Sosa, Jose Francisco, Diaz‐Barrera, Luis Eduardo, and Munoz, Hugo Roberto
- Subjects
- *
CALCITONIN gene-related peptide , *PERIODONTAL ligament , *SUBSTANCE P , *DENTAL pulp cavities , *PEPTIDE receptors - Abstract
Aim: The purpose of this study was to quantify the effect of five different root canal preparation instruments on Substance P (SP), Calcitonin gene‐related peptide (CGRP) and their receptors expression in healthy human periodontal ligament. Methodology: STROBE guidelines were used to design a study using 60 periodontal ligament samples obtained from healthy lower premolars where extraction was indicated for orthodontic reasons. Prior to extraction 40 of these premolars were equally divided into four groups and root canals were prepared using different systems: Mtwo, Reciproc Blue, HyFlex EDM and Plex‐V. Ten premolars were prepared with hand files and served as a positive control group. The remaining 10 premolars where extracted without treatment and served as a negative control group. All periodontal ligament samples were processed to measure the expression of SP, CGRP and their receptors by radioimmunoassay. Kruskal–Wallis and Duncan tests were performed to determine statistically significant differences between the groups for each variable. Results: Greater expression of all the peptides measured were found in the hand‐file preparation group, followed by the Reciproc Blue, Mtwo, HyFlex EDM and Plex‐V groups. The lower SP, CGRP and their receptors values were for the intact teeth control group. Kruskal–Wallis test showed statistically significant differences amongst groups (p <.001). Dunn post‐hoc tests showed statistically significant differences in SP, CGRP and their receptors expression between the intact teeth and the hand‐file and Reciproc Blue groups. Hand‐file group showed significant differences with the other groups, except with Reciproc Blue, where no differences were observed in any of the peptides measured. Finally, no differences were observed between Plex‐V and HyFlex in any of the peptides measured. Conclusions: Root canal preparation with hand files and Reciproc Blue generates the highest expression of SP, CGRP, NK1 and CGRP1R in human periodontal ligament, whilst Plex‐V and HyFlex maintain the basal expression of neuropeptides and their receptors. Mtwo showed intermediate results between Reciproc Blue and HyFlex. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Role of neurogenic inflammation in the pathogenesis of alopecia areata.
- Author
-
Shi, Yetan, Wan, Sheng, and Song, Xiuzu
- Abstract
Alopecia areata refers to an autoimmune illness indicated by persistent inflammation. The key requirement for alopecia areata occurrence is the disruption of immune‐privileged regions within the hair follicles. Recent research has indicated that neuropeptides play a role in the damage to hair follicles by triggering neurogenic inflammation, stimulating mast cells ambient the follicles, and promoting apoptotic processes in keratinocytes. However, the exact pathogenesis of alopecia areata requires further investigation. Recently, there has been an increasing focus on understanding the mechanisms of immune diseases resulting from the interplay between the nervous and the immune system. Neurogenic inflammation due to neuroimmune disorders of the skin system may disrupt the inflammatory microenvironment of the hair follicle, which plays a crucial part in the progression of alopecia areata. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Plasma levels of neurogenic inflammation related neuropeptides in pediatric patients with community-acquired pneumonia and their potential diagnostic value in distinguishing viral and bacterial pneumonia.
- Author
-
Bekdas, Mervan, Saygi, Bilgi, Kilinc, Yasemin Baranoglu, and Kilinc, Erkan
- Subjects
- *
COMMUNITY-acquired pneumonia , *CHILD patients , *NEUROPEPTIDES , *CALCITONIN gene-related peptide , *NEUROPEPTIDE Y - Abstract
Neurogenic inflammation is involved in the development and progression of respiratory inflammatory diseases. However, its role in community-acquired pneumonia (CAP) remains unclear. We therefore aimed to investigate plasma levels of neurogenic inflammation-related neuropeptides, calcitonin gene-related peptide (CGRP), substance P (SP), vasoactive intestinal peptide (VIP) and neuropeptide Y (NPY), and procalcitonin (PCT) in pediatric patients with CAP and to assess their diagnostic value in viral and bacterial/mixed pneumonia. A total of 124 pediatric patients with CAP (1 month-18 years old) and 56 healthy children of similar ages were prospectively enrolled. The patients were classified as viral (n = 99) and bacterial/mixed (n = 25) pneumonia. Plasma levels of the peptides were quantified by ELISA. ROC analysis was performed to evaluate possible diagnostic value of the peptides. While plasma levels of CGRP, VIP and PCT were significantly higher in patients with CAP than in the control group, respectively, NPY levels were significantly lower. Moreover, plasma levels of all neuropeptides and PCT were significantly higher in bacterial pneumonia patients compared to viral pneumonia patients. ROC analysis revealed that CGRP, SP and NPY had a diagnostic value in distinguishing viral and bacterial/mixed pneumonia. Conclusions: Our findings suggest that these neuropeptides may be implicated in pediatric CAP. CGRP, SP and NPY together may be a promising candidate in distinguishing viral and bacterial/mixed pneumonia, however, for this, further studies are needed. What is Known: • Neurogenic inflammation contributes to the development and progression of respiratory inflammatory diseases such as chronic obstructive pulmonary disease and bronchial asthma. What is New: • Plasma levels of neurogenic inflammation related neuropeptides calcitonin gene-related peptide, substance P, vasoactive intestinal peptide and neuropeptide Y are changed in pediatric community-acquired pneumonia. Calcitonin gene-related peptide, substance P and neuropeptide Y are promising candidates in distinguishing viral and bacterial/mixed pneumonia. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Nerve Growth Factor Shows Biphasic Expression during Adjuvant-Induced Neurogenic Inflammation.
- Author
-
Gujar, Vikramsingh, Pande, Radhika D., and Das, Subhas
- Subjects
- *
NERVE growth factor , *NEUROTROPHINS , *GENE expression , *SPRAGUE Dawley rats , *ADJUVANT arthritis , *THERAPEUTICS - Abstract
Chronic inflammatory diseases are considered the most significant cause of death worldwide. Current treatments for inflammatory diseases are limited due to the lack of understanding of the biological factors involved in early-stage disease progression. Nerve growth factor (NGF) is a neurotrophic factor directly associated with inflammatory and autoimmune diseases like osteoarthritis, multiple sclerosis, and rheumatoid arthritis. It has been shown that NGF levels are significantly upregulated at the site of inflammation and play a crucial role in developing a robust inflammatory response. However, little is known about NGF's temporal expression profile during the initial progressive phase of inflammation. This study aimed to determine the temporal expression patterns of NGF in rat skin (epidermis) during adjuvant-induced arthritis (AIA). Sprague Dawley rats were randomly divided into control and complete Freund's adjuvant (CFA)-treated groups. Levels of NGF were evaluated following unilateral AIA at different time points, and it was found that peripheral inflammation due to AIA significantly upregulated the expression of NGF mRNA and protein in a biphasic pattern. These results suggest that NGF signaling is crucial for initiating and maintaining peripheral neurogenic inflammation in rats during AIA. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Rare presence and function of neuroendocrine cells in the nasal mucosa
- Author
-
Tine Wils, Wout Backaert, Inge Jacobs, Emma Ruysseveldt, Jonathan Cremer, Ellen Dilissen, Dominique M. Bullens, Karel Talavera, Brecht Steelant, Laura Van Gerven, Katleen Martens, and Peter W. Hellings
- Subjects
neuroendocrine cells ,nasal hyperreactivity ,nasal mucosa ,upper airway epithelium ,neurogenic inflammation ,Immunologic diseases. Allergy ,RC581-607 - Abstract
There is growing evidence that neurogenic inflammation contributes to the pathophysiology of upper airway diseases, with nasal hyperreactivity (NHR) being a key symptom. The rare neuroendocrine cells (NECs) in the epithelium have been linked to the pathophysiology of bronchial and intestinal hyperreactivity, however their presence in the nasal mucosa and their potential role in NHR remains unclear. Therefore, we studied the presence of NECs in the nasal epithelium of controls, allergic rhinitis patients and chronic rhinosinusitis with nasal polyps patients, and their link to NHR. The expression of typical NECs markers, CHGA, ASCL1 and CGRP, were evaluated on gene and protein level in human samples using real-time quantitative PCR (RT-qPCR), western blot, immunohistochemistry fluorescence staining, RNA scope assay, flow cytometry and single cell RNA-sequencing. Furthermore, the change in peak nasal inspiratory flow after cold dry air provocation and visual analogue scale scores were used to evaluate NHR or disease severity, respectively. Limited gene expression of the NECs markers CHGA and ASCL1 was measured in patients with upper airway diseases and controls. Gene expression of these markers did not correlate with NHR severity nor disease severity. In vitro, CHGA and ASCL1 expression was also evaluated in primary nasal epithelial cell cultures from patients with upper airway disease and controls using RT-qPCR and western blot. Both on gene and protein level only limited CHGA and ASCL1 expression was found. Additionally, NECs were studied in nasal biopsies of patients with upper airway diseases and controls using immunohistochemistry fluorescence staining, RNA scope and flow cytometry. Unlike in ileum samples, CHGA could not be detected in nasal biopsies of patients with upper airway diseases and control subjects. Lastly, single cell RNA-sequencing of upper airway tissue could not identify a NEC cluster. In summary, in contrast to the bronchi and gut, there is only limited evidence for the presence of NECs in the nasal mucosa, and without correlation with NHR, thereby questioning the relevance of NECs in upper airway pathology.
- Published
- 2024
- Full Text
- View/download PDF
15. Role of substance P in cerebral edema and association with an estimated specific gravity of the brain and an outcome prediction in post-traumatic cerebral edema
- Author
-
Subhas Konar, Dhaval Shukla, B. Indira Devi, Rita Christopher, Nishanth S, Louis Puybasset, Dhritiman Chakrabarti, P. Sundaravadivel, and Shubham Nirmal
- Subjects
Traumatic brain injury ,Neurogenic inflammation ,Serum substance P ,Brain-specific gravity ,Surgery ,RD1-811 ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Purpose: The study aims to evaluate the role of substance P in cerebral edema and outcomes associated with acute TBI. Method: Patients with acute TBI who presented within 6 h and a CT scan showed predominantly cerebral edema were included in the study. Substance P level was assessed from a serum sample collected within 6 h of trauma. We also evaluated the brain-specific gravity using the Brain View software. Result: A total of 160 (128 male) patients were recruited. The median serum substance P concentration was 167.89 (IQR: 101.09–238.2). Substance P concentration was high in the early hours after trauma (p = 0.001). The median specific gravity of the entire brain was 1.04. Patients with a low Glasgow coma scale (GCS) at admission had a high concentration of the substance P. In the univariate analysis, low GCS, elevated serum concentrations of substance P level, high Rotterdam grade, high cerebral edema grade, a high international normalized ratio value, and high blood sugar levels were associated with poor outcomes at six months. In logistic regression analysis, low GCS at admission, high cerebral edema grade, and elevated blood sugar level were strongly associated with poor outcomes at six months. The area under the receiver operating characteristic curve was 0.884 (0.826–0.941). Conclusion: Serum substance P is strongly associated with the severity of cerebral edema after TBI. However, brain-specific gravity does not directly correlate with posttraumatic cerebral edema severity. Serum substance P does not influence the clinical outcome of traumatic brain injury.
- Published
- 2024
- Full Text
- View/download PDF
16. Neurogenic inflammation as a novel treatment target for chronic pain syndromes
- Author
-
Seidel, Matthias F, Hügle, Thomas, Morlion, Barton, Koltzenburg, Martin, Chapman, Victoria, MaassenVanDenBrink, Antoinette, Lane, Nancy E, Perrot, Serge, and Zieglgänsberger, Walter
- Subjects
Chronic Pain ,Pain Research ,Arthritis ,Neurosciences ,Evaluation of treatments and therapeutic interventions ,Aetiology ,2.1 Biological and endogenous factors ,5.1 Pharmaceuticals ,6.1 Pharmaceuticals ,Development of treatments and therapeutic interventions ,Neurological ,Musculoskeletal ,Analgesics ,Opioid ,Anti-Inflammatory Agents ,Non-Steroidal ,Humans ,Migraine Disorders ,Neurogenic Inflammation ,Chronic pain ,NGF ,Substance P ,Nociception ,Inflammation ,CGRP ,Migraine ,Clinical Sciences ,Psychology ,Neurology & Neurosurgery - Abstract
Chronic pain syndrome is a heterogeneous group of diseases characterized by several pathological mechanisms. One in five adults in Europe may experience chronic pain. In addition to the individual burden, chronic pain has a significant societal impact because of work and school absences, loss of work, early retirement, and high social and healthcare costs. Several anti-inflammatory treatments are available for patients with inflammatory or autoimmune diseases to control their symptoms, including pain. However, patients with degenerative chronic pain conditions, some with 10-fold or more elevated incidence relative to these manageable diseases, have few long-term pharmacological treatment options, limited mainly to non-steroidal anti-inflammatory drugs or opioids. For this review, we performed multiple PubMed searches using keywords such as "pain," "neurogenic inflammation," "NGF," "substance P," "nociception," "BDNF," "inflammation," "CGRP," "osteoarthritis," and "migraine." Many treatments, most with limited scientific evidence of efficacy, are available for the management of chronic pain through a trial-and-error approach. Although basic science and pre-clinical pain research have elucidated many biomolecular mechanisms of pain and identified promising novel targets, little of this work has translated into better clinical management of these conditions. This state-of-the-art review summarizes concepts of chronic pain syndromes and describes potential novel treatment strategies.
- Published
- 2022
17. Excimer light effect on neurogenic inflammation in active versus stable psoriasis lesions.
- Author
-
El-Mesidy, Marwa S., Metwally, Yomna A., Nour, Zeinab A., and Elmasry, Maha F.
- Subjects
- *
SUBSTANCE P receptors , *ITCHING , *T helper cells , *SUBSTANCE P , *PSORIASIS , *NEUROGENIC bladder , *VISUAL analog scale - Abstract
Neurogenic inflammation, mediated by T helper 17 cell (Th17) and neurons that release neuropeptides such as substance P (SP), is thought to play a role in the pathogenesis of psoriasis. Excimer light is used in the treatment of psoriasis via induction of T cell apoptosis. The objective of this study is to study the effect of excimer light on active versus stable psoriasis and investigate the levels of substance P and its receptor in both groups. The study included 27 stable and 27 active psoriatic patients as well as 10 matched healthy controls. Clinical examination (in the form of local psoriasis severity index (PSI) and visual analogue scale (VAS)) was done to determine disease severity, level of itching, and quality of life. Tissue levels of SP and neurokinin-1 receptor (NK-1R) were measured by ELISA before and after 9 excimer light sessions in 43 patients. A statistically significant lower levels of PSI and VAS were reached after therapy with no significant difference between the stable and active groups. The mean tissue levels of SP before therapy were significantly higher than the control group. Lower levels of SP and NK-1 receptor were found after treatment overall and in each group. Excimer therapy can be effective for both stable and active plaque psoriasis and this effect could be partly through its role on ameliorating the neurogenic inflammation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Electroacupuncture at Sensitized Acupoints Relieves Somatic Referred Pain in Colitis Rats by Inhibiting Sympathetic-Sensory Coupling to Interfere with 5-HT Signaling Pathway.
- Author
-
Yang, Ying, Qu, Jin-yu, Guo, Hua, Zhou, Hai-ying, Ruan, Xia, Peng, Ying-chun, Shen, Xue-fang, Xiong, Jin, and Wang, Yi-li
- Subjects
INDOLE compounds ,ANIMAL experimentation ,REFERRED pain ,CELLULAR signal transduction ,TREATMENT effectiveness ,RATS ,COMPARATIVE studies ,ACUPUNCTURE points ,ENZYME-linked immunosorbent assay ,COLITIS ,SEROTONIN receptors ,ELECTROACUPUNCTURE ,NOCICEPTIVE pain ,SYMPATHETIC nervous system ,SULFONAMIDES ,DEXTRAN ,SYMPTOMS - Abstract
Objective: To investigate whether electroacupuncture (EA) at sensitized acupoints could reduce sympathetic-sensory coupling (SSC) and neurogenic inflammatory response by interfering with 5-hydroxytryptamine (5-HT)ergic neural pathways to relieve colitis and somatic referred pain, and explore the underlying mechanisms. Methods: Rats were treated with 5% dextran sodium sulfate (DSS) solution for 7 days to establish a colitis model. Twelve rats were randomly divided into the control and model groups according to a random number table (n=6). According to the "Research on Rat Acupoint Atlas", sensitized acupoints and non-sensitized acupoints were determined. Rats were randomly divided into the control, model, Zusanli-EA (ST 36), Dachangshu-EA (BL 25), and Xinshu (BL 15) groups (n=6), as well as the control, model, EA, and EA + GR113808 (a 5-HT inhibitor) groups (n=6). The rats in the control group received no treatment. Acupuncture was administered on 2 days after modeling using the stimulation pavameters: 1 mA, 2 Hz, for 30 min, with sparse and dense waves, for 14 consecutive days. GR113808 was injected into the tail vein at 5 mg/kg before EA for 10 min for 7 consecutive days. Mechanical sensitivity was assessed with von Frey filaments. Body weight and disease activity index (DAI) scores of rats were determined. Hematoxylin and eosin staining was performed to observe colon histopathology. SSC was analyzed by immunofluorescence staining. Immunohistochemical staining was performed to detect 5-HT and substance P (SP) expressions. The calcitonin gene-related peptide (CGRP) in skin tissue and tyrosine hydroxylase (TH) protein levels in DRG were detected by Western blot. The levels of hyaluronic acid (HA), bradykinin (BK), prostaglandin I2 (PGI2) in skin tissue, 5-HT, tryptophan hydroxylase 1 (TPH1), serotonin transporters (SERT), 5-HT 3 receptor (5-HT3R), and 5-HT 4 receptor (5-HT4R) in colon tissue were measured by enzyme-linked immunosorbent assay (ELISA). Results: BL 25 and ST 36 acupoints were determined as sensitized acupoints, and BL 15 acupoint was used as a non-sensitized acupoint. EA at sensitized acupoints improved the DAI score, increased mechanical withdrawal thresholds, and alleviated colonic pathological damage of rats. EA at sensitized acupoints reduced SSC structures and decreased TH and CGRP expression levels (P<0.05). Furthermore, EA at sensitized acupoints reduced BK, PGI2, 5-HT, 5-HT3R and TPH1 levels, and increased HA, 5-HT4R and SERT levels in colitis rats (P<0.05). GR113808 treatment diminished the protective effect of EA at sensitized acupoints in colitis rats (P<0.05). Conclusion: EA at sensitized acupoints alleviated DSS-induced somatic referred pain in colitis rats by interfering with 5-HTergic neural pathway, and reducing SSC inflammatory response. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Evaluation of Dermatological and Neurological Aspects of the Relationship between Rosacea and Headaches.
- Author
-
Alizada, Merve, Sahin, Turgut, Sener, Ozden, and Kocyigit, Pelin
- Subjects
- *
ROSACEA , *HEADACHE , *PATIENT experience , *MAST cells , *PATIENTS' attitudes , *MIGRAINE - Abstract
This study aimed to investigate the relationship between rosacea and headaches, focusing on different subtypes, as well as the associated clinical features and triggering factors. In this prospective study, 300 patients diagnosed with rosacea and 320 control subjects without rosacea or any connected mast cell activation illness were included. Patients with rosacea were assessed by a dermatologist according to the 2019 updated rosacea classification (ROSCO panel). Accordingly, patients were classified based on their predominant rosacea subtype as follows: erythematotelangiectatic (ETR), papulopustular (PPR), or phymatous (RhR). Patients experiencing headaches were assessed using the International Headache Classification. Headaches were categorized as migraine, tension-type headaches (TTHs), secondary types (STHs), and cluster-type headaches (CTHs). The ratio of headache was 30.3% in the rosacea group, which did not show a significant difference compared to the control group (30.3% vs. 25.0%, p = 0.138). In 81.3% of rosacea patients with headaches, headache onset occurred after the diagnosis of rosacea. The rate of patients with headaches was higher in the ETR group compared to the PPR and RhR groups (35.2% vs. 16.2% vs. 23.1%, p = 0.007, respectively). In terms of headache subtypes, the rates of patients with migraine and STHs were higher in the ETR group compared to the PPR and RhR groups, while the rate of patients with TTHs was higher in the RhR group. A positive correlation was found between rosacea severity and migraine severity (r = 0.284, p < 0.05). Among the triggering factors for rosacea, only sunlight was found to be associated with headaches. Lower age, female gender, and moderate to severe rosacea severity were identified as independent factors increasing the likelihood of headaches. A significant portion of rosacea patients experience headaches. Particularly, different subtypes of rosacea may be associated with various types of headaches. This study, highlighting the connection between migraine and ETR, is a pioneering work that demonstrates common pathogenic mechanisms and potential triggers. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. Neuroimmune communication in allergic rhinitis.
- Author
-
Yi Zhou, Ru Chen, Lili Kong, Yaoyao Sun, and Jing Deng
- Subjects
ALLERGIC rhinitis ,CALCITONIN gene-related peptide ,NERVE growth factor ,G protein coupled receptors ,VASOACTIVE intestinal peptide ,COMMUNICATIVE disorders - Abstract
The prevalence rate of allergic rhinitis (AR) is high worldwide. The inhalation of allergens induces AR, which is an immunoglobulin E-mediated and type 2 inflammation-driven disease. Recently, the role of neuroimmune communication in AR pathogenesis has piqued the interest of the scientific community. Various neuropeptides, such as substance P (SP), vasoactive intestinal peptide (VIP), calcitonin gene-related peptide (CGRP), nerve growth factor (NGF), and neuromedin U (NMU), released via "axon reflexes" or "central sensitization" exert regulatory effects on immune cells to elicit "neurogenic inflammation," which contributes to nasal hyperresponsiveness (NHR) in AR. Additionally, neuropeptides can be produced in immune cells. The frequent colocalization of immune and neuronal cells at certain anatomical regions promotes the establishment of neuroimmune cell units, such as nerve-mast cells, nerve-type 2 innate lymphoid cells (ILC2s), nerve-eosinophils and nerve-basophils units. Receptors expressed both on immune cells and neurons, such as TRPV1, TRPA1, and Mas-related G protein-coupled receptor X2 (MRGPRX2) mediate AR pathogenesis. This review focused on elucidating the mechanisms underlying neuroimmune communication in AR. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. The microbiota-gut-brain-immune interface in the pathogenesis of neuroinflammatory diseases: a narrative review of the emerging literature
- Author
-
Alison Warren, Yvonne Nyavor, Nikkia Zarabian, Aidan Mahoney, and Leigh A. Frame
- Subjects
human gastrointestinal microbiome ,gut-brain axis ,neuroimmunomodulation ,enteric nervous system ,neurogenic inflammation ,neurodegenerative diseases ,Immunologic diseases. Allergy ,RC581-607 - Abstract
ImportanceResearch is beginning to elucidate the sophisticated mechanisms underlying the microbiota-gut-brain-immune interface, moving from primarily animal models to human studies. Findings support the dynamic relationships between the gut microbiota as an ecosystem (microbiome) within an ecosystem (host) and its intersection with the host immune and nervous systems. Adding this to the effects on epigenetic regulation of gene expression further complicates and strengthens the response. At the heart is inflammation, which manifests in a variety of pathologies including neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and Multiple Sclerosis (MS).ObservationsGenerally, the research to date is limited and has focused on bacteria, likely due to the simplicity and cost-effectiveness of 16s rRNA sequencing, despite its lower resolution and inability to determine functional ability/alterations. However, this omits all other microbiota including fungi, viruses, and phages, which are emerging as key members of the human microbiome. Much of the research has been done in pre-clinical models and/or in small human studies in more developed parts of the world. The relationships observed are promising but cannot be considered reliable or generalizable at this time. Specifically, causal relationships cannot be determined currently. More research has been done in Alzheimer’s disease, followed by Parkinson’s disease, and then little in MS. The data for MS is encouraging despite this.Conclusions and relevanceWhile the research is still nascent, the microbiota-gut-brain-immune interface may be a missing link, which has hampered our progress on understanding, let alone preventing, managing, or putting into remission neurodegenerative diseases. Relationships must first be established in humans, as animal models have been shown to poorly translate to complex human physiology and environments, especially when investigating the human gut microbiome and its relationships where animal models are often overly simplistic. Only then can robust research be conducted in humans and using mechanistic model systems.
- Published
- 2024
- Full Text
- View/download PDF
22. Advances in corneal nerve regulation of ocular surface microenvironment
- Author
-
Ming Chang, Xiong-Shi Lin, and Shuang-Yong Wang
- Subjects
corneal nerve ,ocular surface microenvironment ,corneal neovascularization ,neurogenic inflammation ,wound healing ,Ophthalmology ,RE1-994 - Abstract
The cornea is a transparent outer layer of the anterior eye segment, innervated by a high density of neural tissue. In the process of corneal innervation, trigeminal ganglion originated corneal nerves traverse different types of corneal cell in the epithelial and stromal layers. Corneal stromal cells, epithelial cells, immune cells, and other cells interact closely to maintain corneal microenvironmental homeostasis. In addition, corneal nerves is associated with the occurrence and development of many ocular surface diseases. Corneal nerves release various active peptides that regulate corneal sensation, maintain epithelial integrity and proliferation, improve wound healing, and manage local inflammation and immune response. This article reviews the advances in the corneal nerve regulation of the ocular surface microenvironment, providing some new ideas for the further study and treatment of corneal nerve-associated diseases.
- Published
- 2023
- Full Text
- View/download PDF
23. IBM Watson AI-enhanced search tool identifies novel candidate genes and provides insight into potential pathomechanisms of traumatic heterotopic ossification
- Author
-
Nichola Foster, Fiona M. Wood, Mark Fear, Nathan Pavlos, Edward Raby, and Dale W. Edgar
- Subjects
Heterotopic ossification ,Burn injury ,Neurogenic inflammation ,Machine learning ,Data analytics ,Dermatology ,RL1-803 ,Medical emergencies. Critical care. Intensive care. First aid ,RC86-88.9 - Abstract
Background: Traumatic heterotopic ossification (tHO) is the pathological formation of ectopic bone in soft tissues that can occur following injury to the skin, nervous system, or direct musculoskeletal trauma. Relatively high rates of tHO are expected after damage to neural structures. In clinical practice, diagnosis, prevention, and treatment of tHO are highly variable, partly due to a limited understanding of the pathophysiology. Identifying critical molecular contributors to the development of tHO remains challenging, limiting the development of effective diagnostics and treatment.IBM Watson for Drug Discovery (WDD) uses machine learning and natural language processing to interrogate a literature repository encompassing private and public data sources. This study used WDD to identify plausible new genes and pathways that may be involved in tHO. Methods: A three-stage process centred around the disease agnostic WDD repository was applied during this study. Firstly, WDD was used to pool and target search the scientific literature involving heterotopic ossification arising from burns, orthopaedic trauma, and neurological injury populations. This training of the WDD natural language processing algorithms using known entities was used to discover novel intercepts in the network of semantic relationships evident in the published literature to 2019. Indications of plausible relationships were sought by triangulating biological concepts such as genes and diseases. In this step, using the WDD predictive analytics engine, the study identified and ranked 233 candidate genes that may be associated with pathological ectopic ossification, utilising a set of 100 genes with previously defined associations with tHO. Finally, a search of the WDD-linked literature related to the top 25 genes identified from the rank product analysis was conducted to validate WDD’s predictions of potential novel candidate genes. Results: Of the top 25 ranked genes, six genes (MMRN1, MSC/MyoR, ITGAM/CD11b, PDGF-D, GREM-1 and NELL-1) were identified to have evidence of likely association with tHO. These candidate genes had previously defined roles in inflammation, aberrant tissue repair and regeneration, extracellular matrix remodelling and mineralisation, endochondral or intramembranous bone formation and injury-associated bone reactions, as well as functions in WNT and BMP signalling that are known to be important in osteogenic differentiation. Conclusions: Using a machine-learning approach, this study identified a novel set of plausible candidate gene targets associated with tHO. Machine-learning methods may effectively support target discovery and understanding of pathophysiology in complex disease states.
- Published
- 2023
- Full Text
- View/download PDF
24. Advances in the study of the effects of gut microflora on microglia in Alzheimer's disease.
- Author
-
Jin-Jing Wu and Zhe Wei
- Subjects
ALZHEIMER'S disease ,MICROGLIA ,TAU proteins ,DEGENERATION (Pathology) ,CENTRAL nervous system ,CELL communication - Abstract
Alzheimer's disease (AD) is a central nervous system (CNS) degenerative disorder, is caused by various factors including b-amyloid toxicity, hyperphosphorylation of tau protein, oxidative stress, and others. The dysfunction of microglia has been associated with the onset and advancement of different neurodevelopmental and neurodegenerative disorders, such as AD. The gut of mammals harbors a vast and complex population of microorganisms, commonly referred to as the microbiota. There's a growing recognition that these gut microbes are intrinsically intertwined with mammalian physiology. Through the circulation of metabolites, they establish metabolic symbiosis, enhance immune function, and establish communication with different remote cells, including those in the brain. The gut microbiome plays a crucial part in influencing the development and performance of microglia, as indicated by recent preclinical studies. Dysbiosis of the intestinal flora leads to alterations in the microglia transcriptome that regulate the interconversion of microglia subtypes. This conversation explores recent research that clarifies how gut bacteria, their byproducts, and harmful elements affect the activation and characteristics of microglia. This understanding opens doors to innovative microbial-based therapeutic strategies for early identification and treatment goals in AD. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
25. Potential drug targets for asthma identified in the plasma and brain through Mendelian randomization analysis.
- Author
-
Yuting Wang, Jiaxi Wang, Zhanfeng Yan, Siming Liu, and Wenlong Xu
- Subjects
DRUG target ,ASTHMA ,WHEEZE ,PROTEIN-protein interactions ,LOCUS (Genetics) - Abstract
Background: Asthma is a heterogeneous disease, and the involvement of neurogenic inflammation is crucial in its development. The standardized treatments focus on alleviating symptoms. Despite the availability of medications for asthma, they have proven to be inadequate in controlling relapses and halting the progression of the disease. Therefore, there is a need for novel drug targets to prevent asthma. Methods: We utilized Mendelian randomization to investigate potential drug targets for asthma. We analyzed summary statistics from the UK Biobank and then replicated our findings in GWAS data by Demenais et al. and the FinnGen cohort. We obtained genetic instruments for 734 plasma and 73 brain proteins from recently reported GWAS. Next, we utilized reverse causal relationship analysis, Bayesian co-localization, and phenotype scanning as part of our sensitivity analysis. Furthermore, we performed a comparison and protein-protein interaction analysis to identify causal proteins. We also analyzed the possible consequences of our discoveries by the given existing asthma drugs and their targets. Results: Using Mendelian randomization analysis, we identified five protein-asthma pairs that were significant at the Bonferroni level (P < 6.35 x 10
-5 ). Specifically, in plasma, we found that an increase of one standard deviation in IL1R1 and ECM1 was associated with an increased risk of asthma, while an increase in ADAM19 was found to be protective. The corresponding odds ratios were 1.03 (95% CI, 1.02-1.04), 1.00 (95% CI, 1.00-1.01), and 0.99 (95% CI, 0.98-0.99), respectively. In the brain, per 10-fold increase in ECM1 (OR, 1.05; 95% CI, 1.03-1.08) and PDLIM4 (OR, 1.05; 95% CI, 1.04-1.07) increased the risk of asthma. Bayesian co-localization found that ECM1 in the plasma (coloc.abf-PPH4 = 0.965) and in the brain (coloc.abf-PPH4 = 0.931) shared the same mutation with asthma. The target proteins of current asthma medications were found to interact with IL1R1. IL1R1 and PDLIM4 were validated in two replication cohorts. Conclusion: Our integrative analysis revealed that asthma risk is causally affected by the levels of IL1R1, ECM1, and PDLIM4. The results suggest that these three proteins have the potential to be used as drug targets for asthma, and further investigation through clinical trials is needed. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
26. Epigenetic Connections of the TRPA1 Ion Channel in Pain Transmission and Neurogenic Inflammation — a Therapeutic Perspective in Migraine?
- Author
-
Fila, Michal, Pawlowska, Elzbieta, Szczepanska, Joanna, and Blasiak, Janusz
- Abstract
Persistent reprogramming of epigenetic pattern leads to changes in gene expression observed in many neurological disorders. Transient receptor potential cation channel subfamily A member 1 (TRPA1), a member of the TRP channels superfamily, is activated by many migraine triggers and expressed in trigeminal neurons and brain regions that are important in migraine pathogenesis. TRP channels change noxious stimuli into pain signals with the involvement of epigenetic regulation. The expression of the TRPA1 encoding gene, TRPA1, is modulated in pain-related syndromes by epigenetic alterations, including DNA methylation, histone modifications, and effects of non-coding RNAs: micro RNAs (miRNAs), long non-coding RNAs, and circular RNAs. TRPA1 may change epigenetic profile of many pain-related genes as it may modify enzymes responsible for epigenetic modifications and expression of non-coding RNAs. TRPA1 may induce the release of calcitonin gene related peptide (CGRP), from trigeminal neurons and dural tissue. Therefore, epigenetic regulation of TRPA1 may play a role in efficacy and safety of anti-migraine therapies targeting TRP channels and CGRP. TRPA1 is also involved in neurogenic inflammation, important in migraine pathogenesis. The fundamental role of TRPA1 in inflammatory pain transmission may be epigenetically regulated. In conclusion, epigenetic connections of TRPA1 may play a role in efficacy and safety of anti-migraine therapy targeting TRP channels or CGRP and they should be further explored for efficient and safe antimigraine treatment. This narrative/perspective review presents information on the structure and functions of TRPA1 as well as role of its epigenetic connections in pain transmission and potential in migraine therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
27. The Role of Neuroinflammation in Complex Regional Pain Syndrome: A Comprehensive Review
- Author
-
Wen B, Pan Y, Cheng J, Xu L, and Xu J
- Subjects
complex regional pain syndrome ,neuroinflammation ,neurogenic inflammation ,glial cells ,keratinocytes ,Medicine (General) ,R5-920 - Abstract
Bei Wen,1 Yinbing Pan,2 Jianguo Cheng,3,4 Li Xu,1 Jijun Xu3,5 1Department of Anesthesiology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, 100730, People’s Republic of China; 2Department of Anesthesiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, People’s Republic of China; 3Department of Pain Management, Cleveland Clinic, Cleveland, OH, 44195, USA; 4Department of Neuroscience, Cleveland Clinic, Cleveland, OH, 44195, USA; 5Department of Inflammation and Immunity; Cleveland Clinic, Cleveland, OH, 44195, USACorrespondence: Li Xu; Jijun Xu, Email pumchxuli@163.com; xuj3@ccf.orgAbstract: Complex Regional Pain Syndrome (CRPS) is an excess and/or prolonged pain and inflammation condition that follows an injury to a limb. The pathogenesis of CRPS is multifaceted that remains incompletely understood. Neuroinflammation is an inflammatory response in the peripheral and central nervous systems. Dysregulated neuroinflammation plays a crucial role in the initiation and maintenance of pain and nociceptive neuronal sensitization, which may contribute to the transition from acute to chronic pain and the perpetuation of chronic pain in CRPS. The key features of neuroinflammation encompass infiltration and activation of inflammatory cells and the production of inflammatory mediators in both the central and peripheral nervous systems. This article reviews the role of neuroinflammation in the onset and progression of CRPS from six perspectives: neurogenic inflammation, neuropeptides, glial cells, immune cells, cytokines, and keratinocytes. The objective is to provide insights that can inform future research and development of therapeutic targets for CRPS.Keywords: complex regional pain syndrome, neuroinflammation, neurogenic inflammation, glial cells, keratinocytes
- Published
- 2023
28. BotulInum Toxin Type A for Peripheral Neuropathic Pain in subjEcts With Carpal Tunnel Syndrome (INjECT)
- Author
-
Francesco Bono, Principal Investigator
- Published
- 2022
29. Nerve Growth Factor Shows Biphasic Expression during Adjuvant-Induced Neurogenic Inflammation
- Author
-
Vikramsingh Gujar, Radhika D. Pande, and Subhas Das
- Subjects
inflammation ,nerve growth factor (NGF) ,neurogenic inflammation ,acute inflammation ,nociception ,NGF-TrkA signaling ,Biology (General) ,QH301-705.5 ,Chemistry ,QD1-999 - Abstract
Chronic inflammatory diseases are considered the most significant cause of death worldwide. Current treatments for inflammatory diseases are limited due to the lack of understanding of the biological factors involved in early-stage disease progression. Nerve growth factor (NGF) is a neurotrophic factor directly associated with inflammatory and autoimmune diseases like osteoarthritis, multiple sclerosis, and rheumatoid arthritis. It has been shown that NGF levels are significantly upregulated at the site of inflammation and play a crucial role in developing a robust inflammatory response. However, little is known about NGF’s temporal expression profile during the initial progressive phase of inflammation. This study aimed to determine the temporal expression patterns of NGF in rat skin (epidermis) during adjuvant-induced arthritis (AIA). Sprague Dawley rats were randomly divided into control and complete Freund’s adjuvant (CFA)-treated groups. Levels of NGF were evaluated following unilateral AIA at different time points, and it was found that peripheral inflammation due to AIA significantly upregulated the expression of NGF mRNA and protein in a biphasic pattern. These results suggest that NGF signaling is crucial for initiating and maintaining peripheral neurogenic inflammation in rats during AIA.
- Published
- 2024
- Full Text
- View/download PDF
30. Cytokines in primary headache disorders: a systematic review and meta-analysis
- Author
-
Abdu Kisekka Musubire, Sanjay Cheema, Jason C. Ray, Elspeth J. Hutton, and Manjit Matharu
- Subjects
Migraine disorders ,Tension-type headache ,Cytokine ,Neurogenic inflammation ,Immunology ,Medicine - Abstract
Abstract Background The role of inflammation and cytokines in the pathophysiology of primary headache disorders is uncertain. We performed a systematic review and meta-analysis to synthesise the results of studies comparing peripheral blood cytokine levels between patients with migraine, tension-type headache, cluster headache, or new daily persistent headache (NDPH), and healthy controls; and in migraine between the ictal and interictal stages. Methods We searched PubMed/Medline and Embase from inception until July 2022. We included original research studies which measured unstimulated levels of any cytokines in peripheral blood using enzyme-linked immunosorbent assay or similar assay. We assessed risk of bias using the Newcastle–Ottawa Quality Assessment Scale. We used random effects meta-analysis with inverse variance weighted average to calculate standardised mean difference (SMD), 95% confidence intervals, and heterogeneity for each comparison. This study is registered with PROSPERO (registration number CRD42023393363). No funding was received for this study. Results Thirty-eight studies, including 1335 patients with migraine (32 studies), 302 with tension-type headache (nine studies), 42 with cluster headache (two studies), and 1225 healthy controls met inclusion criteria. Meta-analysis showed significantly higher interleukin (IL)-6 (SMD 1.07, 95% CI 0.40–1.73, p = 0.002), tumour necrosis factor (TNF)-α (SMD 0.61, 95% CI 0.14–1.09, p = 0.01), and IL-8 (SMD 1.56, 95% CI 0.03–3.09, p = 0.04), in patients with migraine compared to healthy controls, and significantly higher interleukin-1β (IL-1β) (SMD 0.34, 95% CI 0.06–0.62, p = 0.02) during the ictal phase of migraine compared to the interictal phase. Transforming growth factor (TGF)-β (SMD 0.52, 95% CI 0.18–0.86, p = 0.003) and TNF-α (SMD 0.64, 95% CI 0.33–0.96, p = 0.0001) were both higher in patients with tension-type headache than controls. Conclusions The higher levels of the proinflammatory cytokines IL-6, IL-8 and TNF-α in migraine compared to controls, and IL-1β during the ictal stage, suggest a role for inflammation in the pathophysiology of migraine, however prospective studies are required to confirm causality and investigate the mechanisms for the increase in cytokine levels identified. Cytokines may also have a role in tension-type headache. Due a lack of data, no conclusions can be made regarding cluster headache or NDPH.
- Published
- 2023
- Full Text
- View/download PDF
31. Neuroimmune communication in allergic rhinitis
- Author
-
Yi Zhou, Ru Chen, Lili Kong, Yaoyao Sun, and Jing Deng
- Subjects
allergic rhinitis (AR) ,neuroimmune communication ,neuropeptides ,neurogenic inflammation ,nasal hyperresponsiveness (NHR) ,neuroimmune cell units ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
The prevalence rate of allergic rhinitis (AR) is high worldwide. The inhalation of allergens induces AR, which is an immunoglobulin E-mediated and type 2 inflammation-driven disease. Recently, the role of neuroimmune communication in AR pathogenesis has piqued the interest of the scientific community. Various neuropeptides, such as substance P (SP), vasoactive intestinal peptide (VIP), calcitonin gene-related peptide (CGRP), nerve growth factor (NGF), and neuromedin U (NMU), released via “axon reflexes” or “central sensitization” exert regulatory effects on immune cells to elicit “neurogenic inflammation,” which contributes to nasal hyperresponsiveness (NHR) in AR. Additionally, neuropeptides can be produced in immune cells. The frequent colocalization of immune and neuronal cells at certain anatomical regions promotes the establishment of neuroimmune cell units, such as nerve-mast cells, nerve-type 2 innate lymphoid cells (ILC2s), nerve-eosinophils and nerve-basophils units. Receptors expressed both on immune cells and neurons, such as TRPV1, TRPA1, and Mas-related G protein-coupled receptor X2 (MRGPRX2) mediate AR pathogenesis. This review focused on elucidating the mechanisms underlying neuroimmune communication in AR.
- Published
- 2023
- Full Text
- View/download PDF
32. Optimizing examination time and diagnostic performance of the histamine‐induced axon‐reflex flare response in diabetes.
- Author
-
Røikjer, Johan, Croosu, Suganthiya Santhiapillai, Borbjerg, Mette Krabsmark, Hansen, Tine Maria, Frøkjær, Jens Brøndum, Arendt‐Nielsen, Lars, Ejskjaer, Niels, and Mørch, Carsten Dahl
- Abstract
Introduction/Aims: The axon‐reflex flare response is a reliable method for functional assessment of small fibers in diabetic peripheral neuropathy (DPN), but broad adoption is limited by the time requirement. The aims of this study were to (1) assess diagnostic performance and optimize time required for assessing the histamine‐induced flare response and (2) associate with established parameters. Methods: A total of 60 participants with type 1 diabetes with (n = 33) or without (n = 27) DPN participated. The participants underwent quantitative sensory testing (QST), corneal confocal microscopy (CCM), and flare intensity and area size assessments by laser‐Doppler imaging (FLPI) following an epidermal skin‐prick application of histamine. The flare parameters were evaluated each minute for 15 min, and the diagnostic performance compared to QST and CCM were assessed using area under the curve (AUC). Minimum time‐requirements until differentiation and to achieve results comparable with a full examination were assessed. Results: Flare area size had better diagnostic performance compared with CCM (AUC 0.88 vs. 0.77, p < 0.01) and QST (AUC 0.91 vs. 0.81, p = 0.02) than mean flare intensity, and could distinguish people with and without DPN after 4 min compared to after 6 min (both p < 0.01). Flare area size achieved a diagnostic performance comparable to a full examination after 6 and 7 min (CCM and QST respectively, p > 0.05), while mean flare intensity achieved it after 5 and 8 min (CCM and QST respectively, p > 0.05). Discussion: The flare area size can be evaluated 6–7 min after histamine‐application, which increases diagnostic performance compared to mean flare intensity. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
33. Toxicological evaluation of a nonlethal riot control combinational formulation upon dermal application using animal models.
- Author
-
Das, Sanghita, Saha, Achintya, Banerjee, Amartya, Goyary, Danswrang, Karmakar, Sanjeev, Dwivedi, Sanjai Kumar, and Chattopadhyay, Pronobesh
- Subjects
RATS ,GUINEA pigs ,SENSORY receptors ,DOPPLER ultrasonography ,ANIMAL models in research ,NERVE endings ,FLOW velocity ,SCANNING electron microscopy - Abstract
Numerous adverse effects on human health have been reported in epidemiological studies of oleoresin capsicum (OC) and other riot control agents (RCAs). Importantly, the daunting risk of such RCAs can be neutralized by optimizing the desired concentration of such agents for mob dispersal. Hence, a nonlethal riot control combinational formulation (NCF) was prepared for dispersing rioters without imparting fatal outcomes. However, for desired utilization of NCF, it is essential to recognize its extent of potential toxicity. Therefore, the current investigation evaluated the dermal toxicity of NCF using experimental animals in compliance with the OECD guidelines. Additionally, few essential metal ions were analyzed and found non -significantly different in the test rats as compared to control rats. Moreover, abnormal dermal morphology and lesions ultrastructural tissue defects were not noticed as evinced by different studies like ultrasonography, histology, and scanning electron microscopy (SEM) respectively. Further, Doppler ultrasonography exhibited non-significantly different blood flow velocity in both groups, whereas miles test demonstrated a significantly increased Evans blue concentration in test rats compared to the control rats, which might be due to an initial increase in blood flow via an instant action of the NCF at the cutaneous sensory nerve endings. However, our results demonstrated NCF can produce initial skin irritating and sensitizing effects in guinea pigs and rabbits without the antecedence of acute toxicity (≤2000 mg/kg) in Wistar rats. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
34. Nociceptor–Macrophage Interactions in Apical Periodontitis: How Biomolecules Link Inflammation with Pain.
- Author
-
Menon, Nandita and Kishen, Anil
- Subjects
- *
PERIAPICAL periodontitis , *SALIVA , *NOCICEPTORS , *BIOMOLECULES , *CALCITONIN gene-related peptide , *TRIGEMINAL nerve , *GINGIVAL fluid - Abstract
Periradicular tissues have a rich supply of peripheral afferent neurons, also known as nociceptive neurons, originating from the trigeminal nerve. While their primary function is to relay pain signals to the brain, these are known to be involved in modulating innate and adaptive immunity by initiating neurogenic inflammation (NI). Studies have investigated neuroanatomy and measured the levels of biomolecules such as cytokines and neuropeptides in human saliva, gingival crevicular fluid, or blood/serum samples in apical periodontitis (AP) to validate the possible role of trigeminal nociceptors in inflammation and tissue regeneration. However, the contributions of nociceptors and the mechanisms involved in the neuro-immune interactions in AP are not fully understood. This narrative review addresses the complex biomolecular interactions of trigeminal nociceptors with macrophages, the effector cells of the innate immune system, in the clinical manifestations of AP. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
35. The Role of Substance P Within Traumatic Brain Injury and Implications for Therapy.
- Author
-
Safwat, Adam, Helmy, Adel, and Gupta, Arun
- Subjects
- *
SUBSTANCE P , *BRAIN injuries , *NEUROPEPTIDES , *CEREBRAL edema , *CENTRAL nervous system , *INTRACRANIAL pressure - Abstract
This review examines the role of the neuropeptide substance P within the neuroinflammation that follows traumatic brain injury. It examines it in reference to its preferential receptor, the neurokinin-1 receptor, and explores the evidence for antagonism of this receptor in traumatic brain injury with therapeutic intent. Expression of substance P increases following traumatic brain injury. Subsequent binding to the neurokinin-1 receptor results in neurogenic inflammation, a cause of deleterious secondary effects that include an increased intracranial pressure and poor clinical outcome. In several animal models of TBI, neurokinin-1 receptor antagonism has been shown to reduce brain edema and the resultant rise in intracranial pressure. A brief overview of the history of substance P is presented, alongside an exploration into the chemistry of the neuropeptide with a relevance to its functions within the central nervous system. This review summarizes the scientific and clinical rationale for substance P antagonism as a promising therapy for human TBI. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
36. Meningeal Mechanisms and the Migraine Connection.
- Author
-
Levy, Dan and Moskowitz, Michael A.
- Subjects
- *
NEURAL stimulation , *DURA mater , *MIGRAINE , *MENINGES , *TRIGEMINAL nerve - Abstract
Migraine is a complex neurovascular pain disorder linked to the meninges, a border tissue innervated by neuropeptide-containing primary afferent fibers chiefly from the trigeminal nerve. Electrical or mechanical stimulation of this nerve surrounding large blood vessels evokes headache patterns as in migraine, and the brain, blood, and meninges are likely sources of headache triggers. Cerebrospinal fluid may play a significant role in migraine by transferring signals released from the brain to overlying pain-sensitive meningeal tissues, including dura mater. Interactions between trigeminal afferents, neuropeptides, and adjacent meningeal cells and tissues cause neurogenic inflammation, a critical target for current prophylactic and abortive migraine therapies. Here we review the importance of the cranial meninges to migraine headaches, explore the properties of trigeminal meningeal afferents, and briefly review emerging concepts, such as meningeal neuroimmune interactions, that may one day prove therapeutically relevant. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
37. Combined carvedilol and gabapentin treatment induces a rapid response in red scrotum syndrome
- Author
-
Mizes, Alicia, Bunimovich, Olga, and Bunimovich, Yuri L
- Subjects
carvedilol ,gabapentin ,neurogenic inflammation ,neuropathic pain ,red scrotum syndrome - Abstract
Red scrotum syndrome (RSS) is a rare dermatologic condition characterized by persistent erythema and analgesia of the male genitalia that cannot be attributed to contact or atopic dermatitis or acute or chronic infections. Treatment of RSS is challenging since it often fails to respond to corticosteroids, antifungals, antivirals, and antibiotics. Several reports described RSS patients who responded to gabapentin, pregabalin, and ?-adrenergic receptor blockers, suggesting a neuropathic etiology. Here we present a refractory RSS case with rapid clinical improvement on a combined carvedilol plus gabapentin therapy. We suggest that RSS manifestations are driven by neurogenic inflammation and that the efficacy of gabapentin/carvedilol relates to the suppression of the neuro-immuno-epidermal axis.
- Published
- 2021
38. Effects of Shiwei Longdanhua formula on LPS induced airway mucus hypersecretion, cough hypersensitivity, oxidative stress and pulmonary inflammation
- Author
-
Liu Wei, Hou Hongping, Li Chufang, Mingji Cuomu, Li Jintao, Cai Kaiyin, Chen Lvyi, Chen Weiwu, Ye Zuguang, and Zhong Nanshan
- Subjects
Pulmonary inflammation ,Oxidative stress ,Mucin hypersecretion ,Neurogenic inflammation ,Airway contraction ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Shiwei Longdanhua Granule (SWLDH) is a classic Tibetan medicine (TM) ranking in the top 20 Chinese patent medicines in prescription rate to treat respiratory diseases like pneumonia, acute and chronic tracheobronchitis, acute exacerbation of COPD and bronchial asthma in solution of inflammation, cough and phlegm obstruction in clinical practice. However, its systematic pharmacological mechanisms have not been elucidated yet. Here, we studied the therapeutic efficacy of SWLDH in treatment of acute respiratory diseases in BALB/c mice by comprehensive analysis of airway inflammation, oxidative stress, mucus hypersecretion, cough hypersensitivities and indicators associated with the development of chronic diseases. Our results show that SWLDH might exhibit its inhibitory effects on pulmonary inflammation by interference with arachidonic acid (AA) metabolism pathways. Oxidative stress that highly related to the degree of tissue injury could be alleviated by enhancing the reductive activities of glutathione redox system, thioredoxin system and the catalytic activities of catalase and superoxide dismutase (SOD) after SWLDH treatment. In addition, SWLDH could significantly abrogate the mucus hypersecretion induced bronchiole obstruction by inactivate the globlet cells and decrease the secretion of gel-forming mucins (MUC5AC and MUC5B) under pathological condition, demonstrating its mucoactive potency. SWLDH also showed reversed effects on the release of neuropeptides that are responsible for airway sensory hypersensitivity. Simultaneously observed inhibition of calcium influx, reduction in in vivo biosynthesis of acetylcholine and the recovery of the content of cyclic adenosine monophosphate (cAMP) might collaboratively contribute to cause airway smooth muscle cells (ASMCs) relexation. These findings indicated that SWLDH might exhibited antitussive potency via suppression of the urge to cough and ASMCs contraction. Moreover, SWLDH might affect airway remodeling. We found SWLDH could retard the elevation of TGF-β1 and α-SMA, which are important indicators for hyperplasia and contraction during the progression of the chronic airway inflammatory diseases like COPD and asthma.
- Published
- 2023
- Full Text
- View/download PDF
39. Roles of mast cells and their interactions with the trigeminal nerve in migraine headache.
- Author
-
Guan, Leo C., Xinzhong Dong, and Green, Dustin P.
- Subjects
- *
TRIGEMINAL nerve , *MAST cells , *MIGRAINE , *ADENYLATE cyclase , *PITUITARY adenylate cyclase activating polypeptide - Abstract
Migraine pain is characterized by an intense, throbbing pain in the head area and possesses complex pathological and physiological origins. Among the various factors believed to contribute to migraine are mast cells (MCs), resident tissue immune cells that are closely associated with pain afferents in the meninges. In this review, we aim to examine and discuss recent findings on the individual roles of MCs and the trigeminal nerve in migraine, as well as the various connections between their mechanisms with an emphasis on the contributions those relationships make to migraine. This is seen through MC release of histamine, among other compounds, and trigeminal nerve release of calcitonin-gene-related-peptide (CGRP) and pituitary adenylate cyclase activating peptide-38 (PACAP-38), which are peptides that are thought to contribute to migraine. Secondly, we illustrate the bi-directional relationship of neurogenic inflammation as well as highlight the role of MCs and their effect on the trigeminal nerve in migraine mechanisms. Lastly, we discuss potential new targets for clinical interventions of MC- and trigeminal nerve-mediated migraine, and present future perspectives of mechanistic and translational research. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
40. Lidocaine alleviates inflammation and pruritus in atopic dermatitis by blocking different population of sensory neurons.
- Author
-
Sun, Pei‐Yi, Li, Hua‐Guo, Xu, Qian‐Yue, Zhang, Zhen, Chen, Jia‐Wen, Shen, Yi‐Hang, Qi, Xin, Lu, Jian‐Fei, Tan, Yi‐Dong, Wang, Xiao‐Xiao, Li, Chun‐Xiao, Yang, Meng‐Ying, Ma, Yu‐Zhi, Lu, Ying, Xu, Tian‐Le, Shen, Jin‐Wen, Li, Wei‐Guang, Guo, Yi‐Feng, and Yao, Zhi‐Rong
- Subjects
- *
ITCHING , *ATOPIC dermatitis , *SENSORY neurons , *CALCITONIN gene-related peptide , *SKIN inflammation , *GENE silencing , *NEUROPHARMACOLOGY - Abstract
Background and Purpose: Atopic dermatitis is a common chronic pruritic inflammatory disease of the skin involving neuro‐immune communication. Neuronal mechanism‐based therapeutic treatments remain lacking. We investigated the efficacy of intravenous lidocaine therapy on atopic dermatitis and the underlying neuro‐immune mechanism. Experimental Approach: Pharmacological intervention, immunofluorescence, RNA‐sequencing, genetic modification and immunoassay were performed to dissect the neuro‐immune basis of itch and inflammation in atopic dermatitis‐like mouse model and in patients. Key Results: Lidocaine alleviated skin lesions and itch in both atopic dermatitis patients and calcipotriol (MC903)‐induced atopic dermatitis model by blocking subpopulation of sensory neurons. QX‐314, a charged NaV blocker that enters through pathologically activated large‐pore ion channels and selectivity inhibits a subpopulation of sensory neurons, has the same effects as lidocaine in atopic dermatitis model. Genetic silencing NaV1.8‐expressing sensory neurons was sufficient to restrict cutaneous inflammation and itch in the atopic dermatitis model. However, pharmacological blockade of TRPV1‐positive nociceptors only abolished persistent itch but did not affect skin inflammation in the atopic dermatitis model, indicating a difference between sensory neuronal modulation of skin inflammation and itch. Inhibition of activity‐dependent release of calcitonin gene‐related peptide (CGRP) from sensory neurons by lidocaine largely accounts for the therapeutic effect of lidocaine in the atopic dermatitis model. Conclusion and Implications: NaV1.8+ sensory neurons play a critical role in pathogenesis of atopic dermatitis and lidocaine is a potential anti‐inflammatory and anti‐pruritic agent for atopic dermatitis. A dissociable difference for sensory neuronal modulation of skin inflammation and itch contributes to further understanding of pathogenesis in atopic dermatitis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
41. A rare case of migrainous left bell's palsy after migrainous right external ophthalmoplegia - A case report.
- Author
-
Kumar, E. A. Ashok, Korivi, Sonali, and Kumar, Siddamshetty Preetham
- Subjects
- *
BELL'S palsy , *FACIAL paralysis , *PRIMARY headache disorders , *EYE paralysis , *MIGRAINE , *FACIAL nerve - Abstract
Migraine increased the risk of Bell palsy in the total population. Among migraine patients, between =30 and <60 years old are at an increased risk of Bell palsy. A migraine is a primary headache characterized by recurrent headache attacks triggered by various factors. As much as 10% of the global population is thought to experience migraine headaches. It was earlier considered that migraine headaches were triggered by the dilation of cerebral vessels, and the recent evidence supports that migraine attacks can also occur in the absence of vasodilation. According to the researchers, the direct neural effects from the trigeminal nerve to the facial nerve could contribute to the risk of facial palsy among patients with migraine. An alteration of the trigeminovascular function has been suggested to trigger migraines. The neurogenic inflammation of the facial nerve trunk caused by its proximity to the dilated posterior auricular/stylomastoid/occipital and superficial temporal arteries during a migraine attack leads to a temporary lower motor neuron type of paresis of the muscles supplied by the facial nerve. We herewith report a rare case of migrainous left Bell's palsy after migrainous right external ophthalmoplegia, treated with Sumatriptan. [ABSTRACT FROM AUTHOR]
- Published
- 2023
42. Corneal epithelial dendritic cells, tear neuropeptides and corneal nerves continue to be affected more than 12 months after LASIK.
- Author
-
Chao, Cecilia, Tajbakhsh, Zahra, Stapleton, Fiona, Mobeen, Rabia, Madigan, Michele C., Jalbert, Isabelle, Briggs, Nancy, and Golebiowski, Blanka
- Subjects
- *
DENDRITIC cells , *EPITHELIAL cells , *CORNEA , *LASIK , *NEUROPEPTIDES - Abstract
Purpose: LASIK causes corneal nerve damage and may affect the neuro‐immune crosstalk. This study examined the effects of LASIK on corneal epithelial dendritic cells (CEDC) density and morphology and explored their relationships with corneal nerves and tear neuropeptides. A grading system was developed to assess CEDC morphology. Methods: Intra‐ and inter‐observer repeatability of the CEDC morphology grading system was established using kappa (κ). In vivo confocal microscope images of the central cornea were captured from 20 participants who had undergone LASIK 12–16 months earlier and 20 controls (age 18–32 years, 55%F). CEDC density was counted manually, and CEDC morphology was assessed using a new grading system. CEDC sub‐types (contacting nerves [CEDCc] and not contacting nerves [CEDCnc]) were also assessed. Differences in CEDC density and morphology were examined using mixed models and chi‐squared test. Relationships between CEDC and corneal nerve parameters and tear substance P were explored using Spearman's correlation. Results: Excellent intra‐ and inter‐observer repeatability was demonstrated for the grading system (κ = 0.82–0.97). In post‐LASIK participants, CEDC density was lower compared with controls (5 [0–34] vs. 21 [7–77] cells/mm2; p = 0.01), and the proportion of CEDC with thick dendrites was higher (55%–73% vs. 11%–21%, p < 0.003). Higher tear substance P levels were associated with higher CEDC density (rho = 0.48, p = 0.003). Fewer nerve interconnections were observed in participants in whom CEDC had dendrites (p = 0.03). CEDC sub‐types followed a similar pattern to CEDC. Conclusions: The findings suggest that CEDC may remain altered more than 12 months post‐LASIK. The association with substance P suggests a role for CEDC in corneal neurogenic inflammation. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
43. Non‐neuronal TRPA1 encodes mechanical allodynia associated with neurogenic inflammation and partial nerve injury in rats.
- Author
-
De Logu, Francesco, De Siena, Gaetano, Landini, Lorenzo, Marini, Matilde, Souza Monteiro de Araujo, Daniel, Albanese, Valentina, Preti, Delia, Romitelli, Antonia, Chieca, Martina, Titiz, Mustafa, Iannone, Luigi F., Geppetti, Pierangelo, and Nassini, Romina
- Subjects
- *
NERVOUS system injuries , *RATS , *SCIATIC nerve injuries , *ALLODYNIA , *GENE silencing , *SCHWANN cells - Abstract
Background and Purpose: The pro‐algesic transient receptor potential ankyrin 1 (TRPA1) channel, expressed by a subpopulation of primary sensory neurons, has been implicated in various pain models in mice. However, evidence in rats indicates that TRPA1 conveys nociceptive signals elicited by channel activators, but not those associated with tissue inflammation or nerve injury. Here, in rats, we explored the TRPA1 role in mechanical allodynia associated with stimulation of peptidergic primary sensory neurons (neurogenic inflammation) and moderate (partial sciatic nerve ligation, pSNL) or severe (chronic constriction injury, CCI) sciatic nerve injury. Experimental Approach: Acute nociception and mechanical hypersensitivity associated with neurogenic inflammation and sciatic nerve injury (pSNL and CCI) were investigated in rats with TRPA1 pharmacological antagonism or genetic silencing. TRPA1 presence and function were analysed in cultured rat Schwann cells. Key Results: Hind paw mechanical allodynia (HPMA), but not acute nociception, evoked by local injection of capsaicin or allyl isothiocyanate, the TRP vanilloid 1 (TRPV1) or the TRPA1 activators was mediated by CGRP released from peripheral sensory nerve terminals. CGRP‐evoked HPMA was sustained by a ROS‐dependent TRPA1 activation, probably in Schwann cells. HPMA evoked by pSNL, but not that evoked by CCI, was mediated by ROS and TRPA1 without the involvement of CGRP. Conclusions and Implications: As found in mice, TRPA1 mediates mechanical allodynia associated with neurogenic inflammation and moderate nerve injury in rats. The channel contribution to mechanical hypersensitivity is a common feature in rodents and might be explored in humans. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
44. Cytokines in primary headache disorders: a systematic review and meta-analysis.
- Author
-
Musubire, Abdu Kisekka, Cheema, Sanjay, Ray, Jason C., Hutton, Elspeth J., and Matharu, Manjit
- Subjects
- *
CYTOKINES , *ONLINE information services , *INTERLEUKINS , *BIOMARKERS , *META-analysis , *MEDICAL information storage & retrieval systems , *INFLAMMATION , *MIGRAINE , *SYSTEMATIC reviews , *EPIDERMAL growth factor receptors , *TENSION headache , *TUMOR necrosis factors , *HEADACHE , *CLUSTER headache , *MEDLINE , *DISEASE complications - Abstract
Background: The role of inflammation and cytokines in the pathophysiology of primary headache disorders is uncertain. We performed a systematic review and meta-analysis to synthesise the results of studies comparing peripheral blood cytokine levels between patients with migraine, tension-type headache, cluster headache, or new daily persistent headache (NDPH), and healthy controls; and in migraine between the ictal and interictal stages. Methods: We searched PubMed/Medline and Embase from inception until July 2022. We included original research studies which measured unstimulated levels of any cytokines in peripheral blood using enzyme-linked immunosorbent assay or similar assay. We assessed risk of bias using the Newcastle–Ottawa Quality Assessment Scale. We used random effects meta-analysis with inverse variance weighted average to calculate standardised mean difference (SMD), 95% confidence intervals, and heterogeneity for each comparison. This study is registered with PROSPERO (registration number CRD42023393363). No funding was received for this study. Results: Thirty-eight studies, including 1335 patients with migraine (32 studies), 302 with tension-type headache (nine studies), 42 with cluster headache (two studies), and 1225 healthy controls met inclusion criteria. Meta-analysis showed significantly higher interleukin (IL)-6 (SMD 1.07, 95% CI 0.40–1.73, p = 0.002), tumour necrosis factor (TNF)-α (SMD 0.61, 95% CI 0.14–1.09, p = 0.01), and IL-8 (SMD 1.56, 95% CI 0.03–3.09, p = 0.04), in patients with migraine compared to healthy controls, and significantly higher interleukin-1β (IL-1β) (SMD 0.34, 95% CI 0.06–0.62, p = 0.02) during the ictal phase of migraine compared to the interictal phase. Transforming growth factor (TGF)-β (SMD 0.52, 95% CI 0.18–0.86, p = 0.003) and TNF-α (SMD 0.64, 95% CI 0.33–0.96, p = 0.0001) were both higher in patients with tension-type headache than controls. Conclusions: The higher levels of the proinflammatory cytokines IL-6, IL-8 and TNF-α in migraine compared to controls, and IL-1β during the ictal stage, suggest a role for inflammation in the pathophysiology of migraine, however prospective studies are required to confirm causality and investigate the mechanisms for the increase in cytokine levels identified. Cytokines may also have a role in tension-type headache. Due a lack of data, no conclusions can be made regarding cluster headache or NDPH. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
45. Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation
- Author
-
Mendiola, Andrew S, Ryu, Jae Kyu, Bardehle, Sophia, Meyer-Franke, Anke, Ang, Kenny Kean-Hooi, Wilson, Chris, Baeten, Kim M, Hanspers, Kristina, Merlini, Mario, Thomas, Sean, Petersen, Mark A, Williams, Alexander, Thomas, Reuben, Rafalski, Victoria A, Meza-Acevedo, Rosa, Tognatta, Reshmi, Yan, Zhaoqi, Pfaff, Samuel J, Machado, Michael R, Bedard, Catherine, Rios Coronado, Pamela E, Jiang, Xiqian, Wang, Jin, Pleiss, Michael A, Green, Ari J, Zamvil, Scott S, Pico, Alexander R, Bruneau, Benoit G, Arkin, Michelle R, and Akassoglou, Katerina
- Subjects
Biomedical and Clinical Sciences ,Immunology ,Neurodegenerative ,Genetics ,Human Genome ,Neurosciences ,Biotechnology ,Brain Disorders ,5.1 Pharmaceuticals ,Development of treatments and therapeutic interventions ,2.1 Biological and endogenous factors ,Aetiology ,Neurological ,Animals ,Antioxidants ,Disease Models ,Animal ,Encephalomyelitis ,Autoimmune ,Experimental ,Female ,Gene Expression Profiling ,Gene Regulatory Networks ,High-Throughput Screening Assays ,Humans ,Immunity ,Innate ,Isoxazoles ,Mice ,Mice ,Inbred C57BL ,Mice ,Mutant Strains ,Microglia ,Multiple Sclerosis ,Neurogenic Inflammation ,Oxidative Stress ,Sequence Analysis ,RNA ,Single-Cell Analysis ,Biochemistry and cell biology - Abstract
Oxidative stress is a central part of innate immune-induced neurodegeneration. However, the transcriptomic landscape of central nervous system (CNS) innate immune cells contributing to oxidative stress is unknown, and therapies to target their neurotoxic functions are not widely available. Here, we provide the oxidative stress innate immune cell atlas in neuroinflammatory disease and report the discovery of new druggable pathways. Transcriptional profiling of oxidative stress-producing CNS innate immune cells identified a core oxidative stress gene signature coupled to coagulation and glutathione-pathway genes shared between a microglia cluster and infiltrating macrophages. Tox-seq followed by a microglia high-throughput screen and oxidative stress gene network analysis identified the glutathione-regulating compound acivicin, with potent therapeutic effects that decrease oxidative stress and axonal damage in chronic and relapsing multiple sclerosis models. Thus, oxidative stress transcriptomics identified neurotoxic CNS innate immune populations and may enable discovery of selective neuroprotective strategies.
- Published
- 2020
46. Pain
- Author
-
Chen, Jun, Han, Ji-Sheng, Zhao, Zhi-Qi, Wei, Feng, Hsieh, Jen-Chuen, Bao, Lan, Chen, Andrew C. N., Dai, Yi, Fan, Bi-Fa, Gu, Jian-Guo, Hao, Shuang-Lin, Hu, San-Jue, Ji, Yong-Hua, Li, Yong-Jie, Li, Yun-Qing, Lin, Qing, Liu, Xian-Guo, Liu, Yan-Qing, Lu, Yan, Luo, Fei, Ma, Chao, Qiu, Yun-Hai, Rao, Zhi-Ren, Shi, Lin, Shyu, Bai-Chuang, Song, Xue-Jun, Tang, Jing-Shi, Tao, Yuan-Xiang, Wan, You, Wang, Jia-Shuang, Wang, Ke-Wei, Wang, Yun, Xu, Guang-Yin, Xu, Tian-Le, You, Hao-Jun, Yu, Long-Chuan, Yu, Sheng-Yuan, Zhang, Da-Ying, Zhang, De-Ren, Zhang, Jun-Ming, Zhang, Xu, Zhang, Yu-Qiu, Zhuo, Min, Pfaff, Donald W., editor, Volkow, Nora D., editor, and Rubenstein, John L., editor
- Published
- 2022
- Full Text
- View/download PDF
47. The Role of the Neuroimmune Network in Allergic Inflammation
- Author
-
Klimov, Vladimir V. and Klimov, Vladimir V.
- Published
- 2022
- Full Text
- View/download PDF
48. Allergies in COVID-19 and Post-COVID Syndrome
- Author
-
Klimov, Vladimir V. and Klimov, Vladimir V.
- Published
- 2022
- Full Text
- View/download PDF
49. Dextrose Prolotherapy for Symptomatic Grade IV Knee Osteoarthritis: A Pilot Study of Early and Longer-Term Analgesia and Pain-Specific Cytokine Concentrations
- Author
-
Gastón Andrés Topol, Ines Guerrero Pestalardo, Kenneth Dean Reeves, Fernando Elias, Neven J. Steinmetz, An-Lin Cheng, and David Rabago
- Subjects
glucose ,neurogenic inflammation ,neuropeptide Y ,cytokine ,nerve ,Medicine (General) ,R5-920 - Abstract
Background: Neurocytokines may upregulate or downregulate neuropathic pain. We hypothesized that dextrose (D-glucose) injections for therapeutic purposes (dextrose prolotherapy: DPT) in painful knee osteoarthritis (KOA) would favorably affect synovial-fluid neurocytokine concentrations. Methods: Twenty participants with grade IV symptomatic KOA received synovial-fluid aspiration followed by dextrose or simulated dextrose injections, followed by the reverse after one week. All participants then received open-label dextrose injections monthly for 6 months, with serial assessments of walking pain at 20 min for 9 months, as well as synovial-neurocytokine-concentration measurements (calcitonin gene-related peptide, substance P (SP), and neuropeptide Y (NPY)) at one week and three months. Results: Clinically important analgesia was observed at 20 min and for 9 months post dextrose injection. One -week synovial-fluid SP concentration rose by 111% (p = 0.028 within groups and p = 0.07 between groups) in the dextrose-injected knees compared to synovial-fluid aspiration only. Three-month synovial-fluid NPY concentration dropped substantially (65%; p < 0.001) after open-label dextrose injection in all knees. Conclusions: Prompt and medium-term analgesia after intra-articular dextrose injection in KOA was accompanied by potentially favorable changes in synovial-fluid neurocytokines SP and NPY, respectively, although these changes were isolated. Including neurocytokines in future assessments of DPT to elucidate mechanisms of action is recommended.
- Published
- 2022
- Full Text
- View/download PDF
50. Research progress on the role of neuropeptides in the pathogenesis of dry eye
- Author
-
Feng Wang, Yi Shao, and Dong Liang
- Subjects
neuropeptides ,dry eye ,pathogenesis ,neurogenic inflammation ,substance p ,calcitonin gene related peptide ,vasoactive intestinal peptide ,Ophthalmology ,RE1-994 - Abstract
Dry eye(DE)is a multi-factorial ocular surface disease. The mechanisms underlying the pathogenesis of DE is still unclear. Inflammation and immune response are considered to be one of the core mechanisms among the pathogenesis of DE. Neuropeptides are small molecular peptides generated after the sensory nerve endings damaged or stimulated. They play an important role in triggering and regulating inflammatory response. Thus, they are important mediums between the nervous system and immune system. Recent studies have revealed that neuropeptides secreted by ocular surface nerves are considered to be an important factor involved in the pathogenesis of DE. Therefore, this paper summarized the research progress on the roles of neuropeptides underlying the mechanisms of the pathogenesis of DE, analyzed the latest points of view and research hot spots, so as to provide references for the prevention and treatment of DE.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.